SOYDAL, Ç. Et Al. 2016. The first experience on Lutetium (lu)-177 prostate specigic andigen (PSMA) treatment in castration resistant prostate cancer patients. Annual Congress of the European Association of Nuclear Medicine , 415.

SOYDAL, Ç., ÖZKAN, E., NAK, D., & KÜÇÜK, N. Ö., (2016). The first experience on Lutetium (lu)-177 prostate specigic andigen (PSMA) treatment in castration resistant prostate cancer patients . Annual Congress of the European Association of Nuclear Medicine (pp.415).

SOYDAL, ÇİĞDEM Et Al. "The first experience on Lutetium (lu)-177 prostate specigic andigen (PSMA) treatment in castration resistant prostate cancer patients," Annual Congress of the European Association of Nuclear Medicine, 2016

SOYDAL, ÇİĞDEM Et Al. "The first experience on Lutetium (lu)-177 prostate specigic andigen (PSMA) treatment in castration resistant prostate cancer patients." Annual Congress of the European Association of Nuclear Medicine , pp.415, 2016

SOYDAL, Ç. Et Al. (2016) . "The first experience on Lutetium (lu)-177 prostate specigic andigen (PSMA) treatment in castration resistant prostate cancer patients." Annual Congress of the European Association of Nuclear Medicine , p.415.

@conferencepaper{conferencepaper, author={ÇİĞDEM SOYDAL Et Al. }, title={The first experience on Lutetium (lu)-177 prostate specigic andigen (PSMA) treatment in castration resistant prostate cancer patients}, congress name={Annual Congress of the European Association of Nuclear Medicine}, city={}, country={}, year={2016}, pages={415} }